Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

BIBF 1120 in Recurrent Glioblastoma Multiforme

This study has been completed.
Sponsor:
Collaborators:
Boehringer Ingelheim
University of Copenhagen
Information provided by (Responsible Party):
Ulrik Lassen, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT01251484
First received: December 1, 2010
Last updated: October 3, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)